Manuel is a Quality Risk Management Specialist at ValGenesis, focusing on helping a variety of pharmaceuticals and biopharmaceutical companies around the globe in implementing different QRM approaches. In addition, he supports the development and validation of the digital solutions that ValGenesis provides to its clients. By accompanying the clients throughout the whole internal implementation process, a good relationship is built between the two parties, that goes beyond the typical vendor-customer relationship. Manuel has a MSc degree in Biological Engineering by the University of Lisbon, Portugal, with a focus on continuing to improve his skills and knowledge in the pharmaceutical industry.
Recent blog posts from Manuel
Is Analytical QbD the Future of Method Development?
This blog post will give you an overview of Analytical QbD and why it's important to implement it in your method development.
Benefit-Risk Assessment for Drug Products
An important, and sometimes challenging, step in every product lifecycle is the point when it gets its premarket or a postmarket regulatory approval by the FDA. Luckily, through a combination of good practices for Benefit-Risk Assessment and technology, this has become much easier.